PFM Health Sciences, LP

Q2 2026 13F-HR Holdings

Location
San Francisco, CA
Holdings as of
6/30/2026
Date filed
8/14/2026
Form type
13F-HR
Num holdings
98
Total value ($000)
$1,165,442
Net value change ($000)
+68,701 (6.3%)
New positions
33
Sold out positions
13
Turnover %
39.8%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/15/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Ascendis Pharma AS 62,191 NEW
HUM 37,488 NEW
UNH 20,985 133.6%
ICLR 17,345 272.6%
MTD 17,047 NEW
MRK 16,335 NEW
CYTK 16,330 NEW
LNTH 16,242 NEW
CVS 14,220 NEW
RVMD 13,133 95.9%
Top Reduces (Value $000, Stocks/ETFs)
THC -51,535 -68.5%
ASND -34,775 -100.0%
PEN -26,884 -58.6%
GKOS -23,221 -100.0%
CNTA -20,981 -100.0%
LLY -13,399 -22.2%
NEO -13,241 -100.0%
DXCM -9,403 -100.0%
TERN -9,119 -100.0%
SLNO -8,309 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 13,614 (1.2% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type